000 00908 a2200253 4500
005 20250517193751.0
264 0 _c20190118
008 201901s 0 0 eng d
022 _a1527-3792
024 7 _a10.1016/j.juro.2017.09.134
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLaguna, M Pilar
245 0 0 _aRe: A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma.
_h[electronic resource]
260 _bThe Journal of urology
_c01 2018
300 _a23-25 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aCarcinoma, Renal Cell
650 0 4 _aHumans
650 0 4 _aKidney Neoplasms
650 0 4 _aPyrroles
650 0 4 _aSunitinib
773 0 _tThe Journal of urology
_gvol. 199
_gno. 1
_gp. 23-25
856 4 0 _uhttps://doi.org/10.1016/j.juro.2017.09.134
_zAvailable from publisher's website
999 _c27956891
_d27956891